Clinical trials in Zagreb – page 8

257 clinical trials in Zagreb, Croatia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in CroatiaKlinicka-Ispitivanja.hr

Zagreb at a glance

257

clinical trials

Research sites3

Quick filters

257 trials in Zagreb

Open in trial search

Ischaemic stroke+1

Recruiting

Study on High-Dose Methylprednisolone and Prednisolone for Children with Stroke Due to Focal Cerebral Arteriopathy

Registered drugNo placebo

Study on High-Dose Methylprednisolone and Prednisolone for Children with Stroke Due to Focal Cerebral Arteriopathy

Registered drugNo placebo

Croatia

Participants:0–17 years
Substances:Prednisolone
Sponsor:Insel Gruppe AG

Contact Research Centre

Generalised tonic-clonic seizure+1

Recruiting

Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

InvestigationalNo placebo

Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

InvestigationalNo placebo

Croatia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azetukalner
Sponsor:Xenon Pharmaceuticals Inc.

Contact Research Centre

Nephrogenic anaemia

Recruiting

Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease

Registered drugNo placebo

Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease

Registered drugNo placebo

Croatia

Participants:0–17 years
Substances:Epoetin Alfa
Sponsor:Astellas Pharma Global Development Inc.

Contact Research Centre

Factor VIII deficiency+1

Recruiting

Study on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors

InvestigationalNo placebo

Study on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors

InvestigationalNo placebo

Croatia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Marstacimab
Sponsor:Pfizer Inc.

Contact Research Centre

Diabetic foot infection

Recruiting

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug

Croatia

Participants:18–64 years · 65+ years
Substances:Aztreonam
Sponsor:Micurx Pharmaceuticals Inc.

Contact Research Centre

Chronic left ventricular failure

Recruiting

Study on Vericiguat for Children with Heart Failure Due to Left Ventricular Systolic Dysfunction

Investigational

Study on Vericiguat for Children with Heart Failure Due to Left Ventricular Systolic Dysfunction

Investigational

Croatia

Participants:0–17 years
Substances:Vericiguat
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Partial seizures

Recruiting

Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

Investigational

Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

Investigational

Croatia

Participants:18–64 years · 65+ years
Substances:Azetukalner
Sponsor:Xenon Pharmaceuticals Inc.

Contact Research Centre

Chronic lymphocytic leukaemia+2

Recruiting

Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

Registered drug

Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

Registered drug

Croatia

Participants:18–64 years · 65+ years
Substances:Sodium Chloride
Sponsor:Grifols Therapeutics LLC

Contact Research Centre

Factor VIII deficiency

Recruiting

Study on the Use of Simoctocog Alfa and Emicizumab for Surgery in Patients with Severe Hemophilia A

Registered drugNo placebo

Study on the Use of Simoctocog Alfa and Emicizumab for Surgery in Patients with Severe Hemophilia A

Registered drugNo placebo

Croatia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Simoctocog Alfa
Sponsor:Octapharma AG

Contact Research Centre

Colitis ulcerative

Recruiting

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Croatia

Participants:0–17 years
Substances:Filgotinib
Sponsor:Alfasigma S.p.A.

Contact Research Centre

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:ABBV-8736
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

Croatia

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Zagreb

What the registry says about research in the country

01 Autoimmune Conditions

Clinical investigations focusing on autoimmune disorders encompass treatments for psoriatic arthritis, Sjögren's Syndrome, and systemic lupus erythematosus, evaluating novel therapeutic approaches for improved patient outcomes.

Psoriatic Arthritis Studies
Sjögren's Syndrome Research
Lupus Treatment Trials

These trials aim to assess new biological medicines and their effectiveness in managing chronic inflammatory conditions.

02 Neurological Disorders

Research initiatives targeting neurological conditions focus on multiple sclerosis and Alzheimer's disease-related psychosis, exploring innovative treatment approaches for better disease management.

Multiple Sclerosis Therapies
Alzheimer's-Related Psychosis
Neurological Disease Management

Studies evaluate both established and emerging treatments to improve patient outcomes and quality of life.

03 Oncology Research

Advanced cancer research programs examine treatments for lung cancer, leukemia, and thyroid cancer, investigating targeted therapies and combination treatments.

Non-Small Cell Lung Cancer
Acute Lymphoblastic Leukemia
Medullary Thyroid Cancer

These trials focus on improving survival rates and developing more effective treatment strategies.

Back to Croatia All countries